It looks like you are using an older browser that is unsupported by our website. To get the best experience, you will need to update your browser. Find out how to update your browser

FTSE 100 shares round-up: big profits and hefty dividends

A number of blue-chip companies just issued updates, with something for seekers of both income and capital. City writer Graeme Evans has the details.

18th November 2026 13:20

by Graeme Evans from interactive investor

Share on

Montage of financial charts and coins representing dividends, Getty

The income and defensive credentials of the FTSE 100 index were today in the spotlight after stocks including Ithaca Energy  Ordinary Share (LSE:ITH), British Land Co (LSE:BLND), SSE (LSE:SSE) and Severn Trent (LSE:SVT) posted updates.

All bar the 10%-yielding Ithaca traded in positive territory, although their share performances were put in the shade by the return to form of Games Workshop Group (LSE:GAW) and Convatec Group (LSE:CTEC).

The Warhammer hobby firm jumped 490p to 17,070p after it used “truly surplus capital” to declare a 105p a share dividend for payment on 27 January.

This takes the running total for the financial year to 405p, with the increase from last year’s 325p a positive sign in relation to recent trading, profitability and cash flow.

The disclosure comes ahead of an update planned for next month, as well as the World Championship of Warhammer in Barcelona between 3-6 December.

The shares hit an all-time high of 21,940p in late June but a torrid autumn has since wiped £2 billion from the company’s value. They were as low as 15,770p in October, which compares with 16,430p before the start of the company’s strong run in mid-February.

Broker Peel Hunt today backed shares with an unchanged target price of 22,000p. It said: “The company delivered a strong performance in 2025-26 and looks well set for another good year.”

ConvaTec shares endured a tough run earlier this year as stocks across the European MedTech sector de-rated due to cost headwinds, uncertainty over US healthcare policy and the rotation of capital towards AI stocks.

The company, which operates in the categories of advanced wound, ostomy, continence and infusion care, started June at 194p following a fall from the 256p seen in late February.

The reverse to a level below the 2016 IPO price of 215p came even though ConvaTec said that the strongest pipeline of innovation in its history underpinned an ambition of “accelerating sustainable and profitable growth”.

The company backed up those upbeat comments in today’s 10-month update, when it raised organic growth guidance for this year to 6.25%-7% from 5.5%-6.5% previously. It also retained its margin target of at least 23% and double-digit growth in adjusted earnings.

Shares rose 21.2p to 268p, which compares with UBS’ price target of 375p.

The bank said ConvaTec’s guidance also materially de-risked the 2027 outlook, adding that the shares have been trading at a 20% discount to peer Coloplast AS Class B (XETRA:CBHD) despite superior growth.

Other strongly performing stocks in the FTSE 100 index included British Land, which lifted 8.2p to 440.2p after it upgraded guidance alongside interim results

The real estate investment trust, whose £10 billion portfolio is focused on London office campuses and UK retail parks, now expects 7% growth in 2026-27 earnings per share to 31p.

The figure rose 5% to 16.1p in today’s results, with the performance boosted by 12% like-for-like net rental growth alongside the positive impact of investment activity and cost controls.

New chief executive Jo McNamara reiterated expectations for earnings growth in the range of 3-6% over the medium term.

She added: “Our core markets represent 90% of our business and offer attractive opportunities, with strong occupational demand and constrained supply supporting further rental growth.”

Today’s share price rise still leaves British Land trading at a 26% discount to the net tangible asset value of 599p per share in today’s results.

The shares are down by 17% in the past five years, having fallen as far as 343p in March due to a combination of higher-for-longer interest rates, rising levels of job vacancies and longer-term fears over the impact of AI adoption.

The shares yield projected dividend income of 5.9%, which is based on Peel Hunt’s forecast for three-year growth of 5% per annum. The latest dividend of 12.88p is payable on 15 January.

Ithaca Energy boasts the highest yield in the FTSE 100 as enhanced cash flows from its operations in the North Sea continue to drive material distributions to shareholders.

The company today made a second upward revision to its 2026 dividend guidance range as its ongoing commitment to return 30% of post-tax cash flow from operations allows investors to benefit from the recent commodity price upside.

It has distributed $1.65 billion (£1.3 billion) since its stock market listing in November 2022, including September’s 15.4 US cents (11.4p) a share dividend worth $255 million.

Today’s uplift to $560-580 million from August’s previously upgraded dividend guidance of $500-530 million represents mid-point growth of $75 million during the year.

The company, which joined the FTSE 100 index in September, reported record quarterly earnings of $663 million as it benefited from a strong production performance and supportive commodity prices.

The shares today slipped 3.8p to 249.8p, which compares with 312.6p prior to the beginning of November’s downturn in crude oil prices.

Ithaca, which holds stakes in six of the 10 largest fields in the UK Continental Shelf, recently announced the acquisition of offshore Canada assets from Suncor.

The Rosebank field in which it has a 20% stake is progressing towards first production in the first half of 2027, subject to regulatory approval.

SSE opened slightly higher at 2,644p after the renewable energy firm said earnings per share for the six months to 30 September rose in line with expectations by 83% to 66.5p.

Regulated networks contributed around two-thirds of adjusted operating profits, driven by a big jump in Transmission as increased investment continues to grow the regulatory asset base.

SSE reiterated its forecast for full-year earnings per share of between 168p and 193p, as well as a 2029-30 target of 225p-250p.

However, Bank of America regards the guidance as too conservative.

It lifted its 2026-27 estimate to 200.3p, which it said reflected the strong Transmission growth and favourable second-half power trading conditions. The bank also boosted its share price target by 110p to 2,880p.

An interim dividend of 22.9p is payable on 5 February and represents growth of 7% based on a policy of distributing one-third of the 2025-26 full-year dividend.

Chief executive Martin Pibworth pointed out that the company had invested a record £2.6 billion in the first half, around 70% of it in regulated electricity networks.

He added: “Deliver lasting value for customers and we can deliver lasting value for shareholders too. That’s the straightforward equation behind our investment plan.

“Our investment is delivering high-quality, regulated earnings, giving us confidence in the plan’s targets.”

Bank of America also has a Buy recommendation on Severn Trent, which today reported interim results in line with expectations.

Half-year profit of £528 million rose 13%, which reflected 7% growth in revenue as well as £23 million of operating efficiencies and the hedging of energy price exposure.

The water company declared an interim dividend of 52.2p for payment on 12 January, which is an increase of 3.6% and in line with its policy to lift the payout by the rate of CPI inflation.

Severn also said it invested £1 billion in its networks and infrastructure in the first six months of the year, almost 40% more than the same period last year.

Shares rose 6p to 3,310p, which compares with June’s 2,842p and BofA’s target price of 3,500p.

These articles are provided for information purposes only.  Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties.  The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

Related Categories

    UK sharesInvestment TrustsIPOsEuropeEditors' picks

Get more news and expert articles direct to your inbox